Ascendis Pharma to report Q1 2026 results and hold webcast on May 7, 2026

Ascendis Pharma announced it will release its first quarter 2026 financial results and provide a business update on May 7, 2026, before U.S. markets open. The company will host a conference call and live webcast at 8:00 a.m. ET to discuss the results. Ascendis Pharma is a biopharmaceutical firm focused on developing innovative therapies using its TransCon technology. This update is important for investors tracking the company's progress and future outlook.